Sarepta Therapeutics | SRPT - 市值

股票价格
20.30
每天变化
-0.12 -0.59%
每月一次
-14.60%
每年
-66.41%
Q2 预测
19.87


金融业
股票价格
USD
资产
USD 3.35B
现金及等价物
USD 801.28M
销售成本
USD 399.39M
流动资产
USD 2.54B
流动负债
USD 1.1B
债务
USD 1.25B
EBIT
USD -410.08M
EBITDA
USD -168.03M
员工
1.37K
EPS每股收益
USD -3.58
股本和储备
USD 1.14B
销售毛利
USD 43.55M
债务利息支出
USD 7.56M
利息收入
USD 8.38M
贷款资金
USD 828.97M
市值
USD 1.92B
净收入
USD -412.23M
营业费用
USD 853.02M
营业利润
USD -410.08M
普通股股本
USD 104.96M
PE价格收益
27.27
税前利润
USD -407.68M
销售收入
USD 442.9M
销售和管理费用
USD 105.38M
股票
USD 914.74M
贸易债权人
USD 280.84M
应收帐款人
USD 398.23M


市值 更改 日
Acadia Pharmaceuticals USD 4.52B 919M 2025-12
Agios Pharmaceuticals USD 1.59B 745M 2025-12
Alnylam Pharmaceuticals USD 52.54B 7.24B 2025-12
Amgen USD 176.25B 24.32B 2025-12
BioCryst Pharmaceuticals USD 1.66B 64M 2025-12
Biogen USD 25.82B 5.28B 2025-12
BioMarin Pharmaceutical USD 11.42B 1.02B 2025-12
Capricor Therapeutics USD 1.66B 1.33B 2025-12
Daiichi Sankyo JPY 6.34T 62.51B 2025-12
Eli Lilly USD 1.02T 293.84B 2025-12
Esperion Therapeutics USD 885M 351M 2025-12
Gilead Sciences USD 166.62B 14.34B 2026-04
Incyte USD 19.39B 2.83B 2025-12
Insmed USD 37.12B 6.68B 2025-12
Ionis Pharmaceuticals USD 12.81B 2.39B 2025-12
Nektar Therapeutics USD 14.34B 13.48B 2026-04
Neurocrine Biosciences USD 14.14B 218M 2025-12
Novavax USD 1.09B 316M 2025-12
Pfizer USD 141.57B 6.48B 2025-12
PTC Therapeutics USD 5.26B 844M 2026-04
Regeneron Pharmaceuticals USD 81.12B 21.53B 2025-12
Roche Holding CHF 266.34B 55.46B 2025-12
Sanofi EUR 101.43B 1.16B 2026-04
Sarepta Therapeutics USD 2.26B 238M 2025-12
Tectonic Therapeutic USD 390M 96M 2025-12
Ultragenyx Pharmaceutical USD 2.22B 680M 2025-12
Vertex Pharmaceuticals USD 115.03B 14.61B 2025-12